'Correction:' Serum transforming growth factor beta-1 (TGF-beta-1) levels in diabetic patients are not associated with pre-existent coronary artery disease

Table 2 Laboratory characteristics of the studied groups

	C	D	C-CAD	D-CAD	P
N	61	23	28	23
Plasma glucose (mg/dl)	93.1 ± 1.4	143.6 ± 14.5*	96.2 ± 2.2	141.8 ± 11.7*	<0.001
HbA1c (%)	5.71 ± 0.05	6.67 ± 0.35*	5.72 ± 0.06	7.08 ± 0.33*	<0.001
TC (mg/dl)	194.4 ± 5.5	201.7 ± 10.2	213.5 ± 7.9	219.6 ± 10.3	0.080
LDL-c (mg/dl)	111.9 ± 4.3	121.3 ± 8.3	126.2 ± 6.3	129.2 ± 8.2	0.144
HDL-c (mg/dl)	49.9 ± 1.5	46.6 ± 1.9	44.5 ± 2.2	45.4 ± 1.9	0.116
Non HDL-c (mg/dl)	142.7 ± 5.6	155.1 ± 9.3	168.4 ± 7.8#	174.2 ± 9.6#	0.009
TG (mg/dl)	160.9 ± 13.7	169.1 ± 15.8	216.4 ± 31.4	224.9 ± 30.7	0.082
Fibrinogen (mg/dl)	348.2 ± 11.4	335.7 ± 19.5	355.9 ± 17.4	353.2 ± 21.8	0.883
CRP (mg/l)	7.63 ± 1.27	4.48 ± 1.13	7.21 ± 2.61	8.57 ± 2.00	0.551
Insulin levels (μU/ml)	12.92 ± 1.3	21.25 ± 6.9	12.1 ± 1.4	17.6 ± 2.6	0.122
HOMA-IR	3.09 ± 0.34	9.06 ± 3.63*	2.99 ± 0.39	6.42 ± 1.16	0.006
TGF B (ng/ml)	35,1 ×/÷ 1,3	33,6 ×/÷ 1,6	33,9 ×/÷ 1,4	31,8 ×/÷ 1,4	0,547

Data are means ± SEM or n (%)
C: no diabetes and no coronary artery disease, D: diabetes and no coronary artery disease, C-CAD: coronary artery disease and no diabetes and D-CAD: coronary artery disease and diabetes; HbA1c: glycated haemoglobin; TC: total cholesterol; LDL-c: low-density lipoprotein cholesterol; HDL-c: high-density lipoprotein cholesterol; TG: triglycerides; HOMA-IR: model of homeostatic evaluation.
*P < 0.001 vs C and C-CAD; # P < 0.05 vs C

ISSN: 1475-2840